The CLL Issue 
Finbarr E Cotter,
Editor in Chief
p. 629–629
Reviews
Chronic lymphocytic leukaemia genetics overview 
Neil Caporaso, Lynn Goldin, Christoph Plass, George Calin, Gerald Marti, Steven Bauer, Elizabeth Raveche, Mary Lou McMaster, David Ng, Ola Landgren and Susan Slager
p. 630–634
Emerging therapy for chronic lymphocytic leukaemia 
Rebecca L. Auer, John Gribben and Finbarr E. Cotter
p. 635–644
Murine models of chronic lymphocytic leukaemia: role of microRNA-16 in the New Zealand Black mouse model 
Brian J. Scaglione, Erica Salerno, Murugabaskar Balan, Frederick Coffman, Pablo Landgraf, Fatima Abbasi, Sergei Kotenko, Gerald E. Marti and Elizabeth S. Raveche
p. 645–657
B cells behaving badly 
Youn K. Shim, Sharon R. Silver, Neil E. Caporaso, Gerald E. Marti, Dannie C. Middleton, Martha S. Linet, and Robert F. Vogt for the 2007 International CLL/MBL Workshop*
p. 658–662
Waldenström macroglobulinaemia and IgM monoclonal gammopathy of undetermined significance: emerging understanding of a potential precursor condition 
Mary L. McMaster and Neil Caporaso
p. 663–671
Chronic lymphocytic leukaemia: an overview of aetiology in light of recent developments in classification and pathogenesis 
Martha S. Linet, Mary K. Schubauer-Berigan, Dennis D. Weisenburger, David B. Richardson, Ola Landgren, Aaron Blair, Sharon Silver, R. William Field, Glyn Caldwell, Maureen Hatch and Graça M. Dores
p. 672–686
Overview of monoclonal gammopathies of undetermined significance 
Robert F. Vogt and Gerald E. Marti
p. 687–689
Monoclonal B-cell lymphocytosis as a biomarker in environmental health studies 
Robert F. Vogt, Youn K. Shim, Dannie C. Middleton, Patricia A. Buffler, Sharon S. Campolucci, Jeffrey A. Lybarger and Gerald E. Marti
p. 690–700
Overview of monoclonal B-cell lymphocytosis 
Gerald Marti, Fatima Abbasi, Elizabeth Raveche, Andy C. Rawstron, Paolo Ghia, Therese Aurran, Neil Caporaso, Youn K. Shim and Robert F. Vogt
p. 701–708
MicroRNAs in the pathogeny of chronic lymphocytic leukaemia 
Milena S. Nicoloso, Thomas J. Kipps, Carlo M. Croce and George A. Calin
p. 709–716
Multiple myeloma, chronic lymphocytic leukaemia and associated precursor diseases 
Ola Landgren and Robert A. Kyle
p. 717–723
The biological and clinical relationship between CD5+23+ monoclonal B-cell lymphocytosis and chronic lymphocytic leukaemia 
Andy C. Rawstron, Fiona Bennett and Peter Hillmen
p. 724–729
Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression 
Robert A. Kyle and S. Vincent Rajkumar
p. 730–743
Molecular profiling of chronic lymphocytic leukaemia: genetics meets epigenetics to identify predisposing genes 
Christoph Plass, John C. Byrd, Aparna Raval, Stephan M. Tanner and Albert de la Chapelle
p. 744–752
Chemical exposures and risk of chronic lymphocytic leukaemia 
Aaron Blair, Mark P. Purdue, Dennis D. Weisenburger and Dalsu Baris
p. 753–761
Susceptibility genes and B-chronic lymphocytic leukaemia 
Susan L. Slager, Neil E. Kay, Zachary S. Fredericksen, Alice H. Wang, Mark Liebow, Julie M. Cunningham, Celine M. Vachon, Timothy G. Call and James R. Cerhan
p. 762–771
Annotation
Cytometry in monoclonal B-cell lymphocytosis and chronic lymphocytic leukaemia – The Hunting of the Snark? 
Howard M. Shapiro
p. 772–773
Research Papers
Family studies in chronic lymphocytic leukaemia and other lymphoproliferative tumours 
Lynn R. Goldin and Neil E. Caporaso
p. 774–779
Age-dependent accumulation of monoclonal CD4+CD8+double positive T lymphocytes in the peripheral blood of the elderly 
Paolo Ghia, Giuseppina Prato, Stefania Stella, Cristina Scielzo, Massimo Geuna and Federico Caligaris-Cappio
p. 780–790
Acquired immune-related and inflammatory conditions and subsequent chronic lymphocytic leukaemia 
Ola Landgren, Gloria Gridley, David Check, Neil E. Caporaso and Linda Morris Brown
p. 791–798
Chronic lymphocytic leukaemia and radiation: findings among workers at five US nuclear facilities and a review of the recent literature 
Mary K. Schubauer-Berigan, Robert D. Daniels, Donald A. Fleming, Andrea M. Markey, James R. Couch, Steven H. Ahrenholz, Jenneh S. Burphy, Jeri L. Anderson and Chih-Yu Tseng
p. 799–808
Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology 
Graça M. Dores, William F. Anderson, Rochelle E. Curtis, Ola Landgren, Evgenia Ostroumova, Elizabeth C. Bluhm, Charles S. Rabkin, Susan S. Devesa and Martha S. Linet
p. 809–819
B-cell repertoire and clonal analysis in unaffected first degree relatives in familial chronic lymphocytic leukaemia kindred 
Fatima Abbasi, Nancy S. Longo, Peter E. Lipsky, Elizabeth Raveche, Therese A. Schleinitz, Maryalice Stetler-Stevenson, Neil Caporaso and Gerald Marti
p. 820–823
Bioethical considerations of monoclonal B-cell lymphocytosis: donor transfer after haematopoietic stem cell transplantation 
Nancy M. Hardy, Christine Grady, Rebecca Pentz, Maryalice Stetler-Stevenson, Mark Raffeld, Laura S. Fontaine, Rebecca Babb, Michael R. Bishop, Neil Caporaso and Gerald E. Marti
p. 824–831
Monoclonal B-cell lymphocytosis in blood donors 
Jane M. Rachel, Marjorie L. Zucker, Christopher M. Fox, Fred V. Plapp, Jay E. Menitove, Fatima Abbasi and Gerald E. Marti
p. 832–836
Rituximab and 17-allylamino-17-demethoxygeldanamycin induce synergistic apoptosis in B-cell chronic lymphocytic leukaemia 
Amy J. Johnson, Amy J. Wagner, Carolyn M. Cheney, Lisa L. Smith, David M. Lucas, Sara K. Guster, Michael R. Grever, Thomas S. Lin and John C. Byrd
p. 837–844
UShort report
Outreach monitoring service for patients with indolent B-cell and plasma cell disorders: a UK experience 
Andy C. Rawstron, Richard A. Jones, Carol Ferguson, Geraint Hughes, Pam Selby, Carol Reid, Surita Dalal, Martin Howard, Graeme Smith, Peter Hillmen, Roger G. Owen and Andrew S. Jack
p. 845–848 |
